Cellosaurus logo
expasy logo

Cellosaurus OCI-AML3DNR (CVCL_D6NF)

[Text][XML][JSON]
Cell line name OCI-AML3DNR
Accession CVCL_D6NF
Resource Identification Initiative To cite this cell line use: OCI-AML3DNR (RRID:CVCL_D6NF)
Comments Population: Caucasian.
Selected for resistance to: ChEBI; CHEBI_41977; Daunorubicin (Daunomycin).
Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
Sequence variations
  • Mutation; HGNC; HGNC:2978; DNMT3A; Simple; p.Arg882Cys (c.2644C>T); ClinVar=VCV000375882; Zygosity=Heterozygous (from parent cell line).
  • Mutation; HGNC; HGNC:7910; NPM1; Simple; p.Trp288Cysfs*12 (c.860_863dupTCTG); ClinVar=VCV000013998; Zygosity=Heterozygous (from parent cell line).
  • Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Homozygous (from parent cell line).
Disease Adult acute myelomonocytic leukemia (NCIt: C7962)
Acute myelomonocytic leukemia (ORDO: Orphanet_517)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Parent: CVCL_1844 (OCI-AML-3)
Sex of cell Male
Age at sampling 57Y
Category Cancer cell line
Publications

PubMed=21679421; DOI=10.1186/1471-2407-11-254; PMCID=PMC3146447
Martin Grundy, Claire Seedhouse, Nigel H. Russell, Monica Pallis;
P-glycoprotein and breast cancer resistance protein in acute myeloid leukaemia cells treated with the aurora-B kinase inhibitor barasertib-hQPA.
BMC Cancer 11:254.1-254.13(2011)

Entry history
Entry creation10-Sep-2024
Last entry update14-Aug-2025
Version number4